Access to Outpatient Prescription and Patient Level Drug Utilization Data

*AMENDMENT 3*

-Please see the attached Questions and Answers.
-Please see the attached updated RFP to reflect the new closing date.
-Appendix K- Past Performance Questionnaire is due by the closing date and time.

-The closing date for proposals has been extended until:
  Wednesday, July 16, 2014 @ 12:00pm ET.

-Proposals must be mailed or hand delivered to:

Food and Drug Administration
Attn: Ashley P. Allen
Office of Acquisitions & Grants Services
5630 Fishers Lane, Room 1079
HFA-500
Rockville, MD 20857

-The proposals shall clearly be marked as "Response to RFP No.: FDA-SOL-1126588 , Access to Outpatient Prescription and Patient Level."

*AMENDMENT 2*

-APPENDIX K- Past Performance Questionnaire is due Friday, July 11, 2014 @ 9:00am ET


*AMENDMENT 1*

-Questions for this RFP are due no later than: Thursday, June 26, 2014 @ 2:00pm ET.
-Proposals for this RFP are due no later than: Friday, July 11, 2014 @ 9:00am ET.



 

This is a combined synopsis/solicitation to obtain Access to Outpatient Prescription and Patient Level Drug Utilization Data utilizing the procedures set forth in FAR Parts 12 & 15. A detailed description of the required services is provided in Attachment 1 to the RFP. The solicitation number is FDA-SOL-1126588.

All questions regarding the RFP shall be submitted to Ashley P. Allen via email at Ashley.Allen@fda.hhs.gov. The FDA must receive the questions no later than Thursday, June 26, 2014 at 2:00 p.m. ET. The subject line shall read: FDA-SOL-1126588, Access to Outpatient Prescription and Patient Level Drug Utilization Data.

FDA will not answer questions received after this date and time. FDA will not answer questions asked via telephone or submitted to any official other than the Contract Specialist. Responses to questions will be posted on www.fbo.gov.

The proposal shall be signed by an authorized official to bind your organization and must be received by the Contract Specialist no later than Friday, July 11, 2014 at 9:00 a.m. ET. Your proposal must be mailed, or hand delivered, to the following address:

U.S. Food and Drug Administration (FDA)
Office of Acquisitions and Grant Services (OAGS)
Attn: Ashley P. Allen
5630 Fishers Lane, Room 1079
Rockville, MD 20857
Ashley.Allen@fda.hhs.gov

Hand delivered proposal may be dropped off at the above location. However, please allow sufficient time as proposals cannot be accepted until they have gone through security. The FDA will not be held responsible for any delays that may be incurred getting your proposal through security.

*AMENDMENT 2*

-APPENDIX K- Past Performance Questionnaire is due Friday, July 11, 2014 @ 9:00am ET


*AMENDMENT 1*

-Questions for this RFP are due no later than: Thursday, June 26, 2014 @ 2:00pm ET.
-Proposals for this RFP are due no later than: Friday, July 11, 2014 @ 9:00am ET.



 

This is a combined synopsis/solicitation to obtain Access to Outpatient Prescription and Patient Level Drug Utilization Data utilizing the procedures set forth in FAR Parts 12 & 15. A detailed description of the required services is provided in Attachment 1 to the RFP. The solicitation number is FDA-SOL-1126588.

All questions regarding the RFP shall be submitted to Ashley P. Allen via email at Ashley.Allen@fda.hhs.gov. The FDA must receive the questions no later than Thursday, June 26, 2014 at 2:00 p.m. ET. The subject line shall read: FDA-SOL-1126588, Access to Outpatient Prescription and Patient Level Drug Utilization Data.

FDA will not answer questions received after this date and time. FDA will not answer questions asked via telephone or submitted to any official other than the Contract Specialist. Responses to questions will be posted on www.fbo.gov.

The proposal shall be signed by an authorized official to bind your organization and must be received by the Contract Specialist no later than Friday, July 11, 2014 at 9:00 a.m. ET. Your proposal must be mailed, or hand delivered, to the following address:

U.S. Food and Drug Administration (FDA)
Office of Acquisitions and Grant Services (OAGS)
Attn: Ashley P. Allen
5630 Fishers Lane, Room 1079
Rockville, MD 20857
Ashley.Allen@fda.hhs.gov

Hand delivered proposal may be dropped off at the above location. However, please allow sufficient time as proposals cannot be accepted until they have gone through security. The FDA will not be held responsible for any delays that may be incurred getting your proposal through security.

*AMENDMENT 1*

-Questions for this RFP are due no later than: Thursday, June 26, 2014 @ 2:00pm ET.
-Proposals for this RFP are due no later than: Friday, July 11, 2014 @ 9:00am ET.



 

This is a combined synopsis/solicitation to obtain Access to Outpatient Prescription and Patient Level Drug Utilization Data utilizing the procedures set forth in FAR Parts 12 & 15. A detailed description of the required services is provided in Attachment 1 to the RFP. The solicitation number is FDA-SOL-1126588.

All questions regarding the RFP shall be submitted to Ashley P. Allen via email at Ashley.Allen@fda.hhs.gov. The FDA must receive the questions no later than Thursday, June 26, 2014 at 2:00 p.m. ET. The subject line shall read: FDA-SOL-1126588, Access to Outpatient Prescription and Patient Level Drug Utilization Data.

FDA will not answer questions received after this date and time. FDA will not answer questions asked via telephone or submitted to any official other than the Contract Specialist. Responses to questions will be posted on www.fbo.gov.

The proposal shall be signed by an authorized official to bind your organization and must be received by the Contract Specialist no later than Friday, July 11, 2014 at 9:00 a.m. ET. Your proposal must be mailed, or hand delivered, to the following address:

U.S. Food and Drug Administration (FDA)
Office of Acquisitions and Grant Services (OAGS)
Attn: Ashley P. Allen
5630 Fishers Lane, Room 1079
Rockville, MD 20857
Ashley.Allen@fda.hhs.gov

Hand delivered proposal may be dropped off at the above location. However, please allow sufficient time as proposals cannot be accepted until they have gone through security. The FDA will not be held responsible for any delays that may be incurred getting your proposal through security.

This is a combined synopsis/solicitation to obtain Access to Outpatient Prescription and Patient Level Drug Utilization Data utilizing the procedures set forth in FAR Parts 12 & 15. A detailed description of the required services is provided in Attachment 1 to the RFP. The solicitation number is FDA-SOL-1126588.

All questions regarding the RFP shall be submitted to Ashley P. Allen via email at Ashley.Allen@fda.hhs.gov. The FDA must receive the questions no later than Thursday, June 6, 2014 at 2:00 p.m. ET. The subject line shall read: FDA-SOL-1126588, Access to Outpatient Prescription and Patient Level Drug Utilization Data.

FDA will not answer questions received after this date and time. FDA will not answer questions asked via telephone or submitted to any official other than the Contract Specialist. Responses to questions will be posted on www.fbo.gov.

The proposal shall be signed by an authorized official to bind your organization and must be received by the Contract Specialist no later than Friday, July 11, 2014 at 9:00 a.m. ET. Your proposal must be mailed, or hand delivered, to the following address:

U.S. Food and Drug Administration (FDA)
Office of Acquisitions and Grant Services (OAGS)
Attn: Ashley P. Allen
5630 Fishers Lane, Room 1079
Rockville, MD 20857
Ashley.Allen@fda.hhs.gov

Hand delivered proposal may be dropped off at the above location. However, please allow sufficient time as proposals cannot be accepted until they have gone through security. The FDA will not be held responsible for any delays that may be incurred getting your proposal through security.